Sabra Health Care REIT, Inc.(SBRA)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #193 of 2,879 stocksTOP 10%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
SBRA Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Sabra Health Care REIT, Inc. (SBRA), a Real Estate sector company. 13F Pro's AI-powered ranking engine scores SBRA at 73.5/100 on a 32-signal composite quality model, placing it at rank #193 of 2,879 stocks — the top 10% of the AI-ranked universe. SBRA scores in the top quartile across free cash flow (96.3), earnings quality (95.8), profitability (95.0). Areas of concern include revenue scale (32.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 47.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Sabra Health Care REIT, Inc. reports quarterly revenue of $221.8M, net income of $40.9M, an operating margin of 17.8%. Top institutional holders of SBRA by reported 13-F value include BlackRock,, PRINCIPAL FINANCIAL GROUP, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. SBRA trades on the Nasdaq exchange and files with the SEC under CIK 1492298. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SBRA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Sabra Health Care REIT, Inc. directly from SEC EDGAR. Sabra Health Care REIT, Inc.'s 13F Pro composite quality score has ranged between 8 and 85 since 2021, currently 73.5 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q1 2026
$221.8M
Net Income
Q1 2026
$40.9M
Free Cash Flow
Q1 2026
$98.4M
Operating Margin
Q1 2026
17.8%
ROIC
Q1 2026
0.7%
D/E Ratio
Q1 2026
0.96
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+10.2% YoYNet Income
+22.8% YoYEPS (Diluted)
+18.5% YoYTotal Assets
+3.6% YoYTotal Debt
+4.6% YoYOp. Cash Flow
+12.3% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $774.6M +10.2% | $703.2M +8.6% | $647.5M +3.6% | $624.8M +4.4% | $598.6M -9.5% | $661.7M |
| Net Income | $155.6M +22.8% | $126.7M +821.1% | $13.8M +117.7% | $-77.6M -156.1% | $138.4M +100.6% | $69.0M |
| EPS (Diluted) | $0.64 +18.5% | $0.54 +800.0% | $0.06 +117.6% | $-0.34 -150.7% | $0.67 +81.1% | $0.37 |
| Total Assets | $5.49B +3.6% | $5.30B -1.5% | $5.39B -6.3% | $5.75B -4.0% | $5.99B -1.4% | $6.07B |
| Total Debt | $2.53B +4.6% | $2.42B +0.1% | $2.41B -3.7% | $2.51B +5.7% | $2.37B -1.2% | $2.40B |
| Operating Cash Flow | $348.6M +12.3% | $310.5M +3.3% | $300.6M -4.8% | $315.7M -11.0% | $354.9M -4.7% | $372.5M |
Get alerted when SBRA's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Sabra Health Care REIT, Inc. including:
Top Institutional Holders of SBRA
BlackRock, Inc.
$751.9M39,098,389 shPRINCIPAL FINANCIAL GROUP INC
$481.8M25,052,121 shVANGUARD PORTFOLIO MANAGEMENT LLC
$445.0M23,143,248 shSTATE STREET CORP
$232.7M12,099,951 shVANGUARD CAPITAL MANAGEMENT LLC
$216.0M11,230,748 shGEODE CAPITAL MANAGEMENT, LLC
$143.3M7,450,769 shNuveen, LLC
$128.3M6,673,284 shBANK OF AMERICA CORP /DE/
$104.0M5,409,161 shCHARLES SCHWAB INVESTMENT MANAGEMENT INC
$91.8M4,773,303 shCENTERSQUARE INVESTMENT MANAGEMENT LLC
$74.6M3,877,810 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $751.9M | 39,098,389 |
| PRINCIPAL FINANCIAL GROUP INC | $481.8M | 25,052,121 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $445.0M | 23,143,248 |
| STATE STREET CORP | $232.7M | 12,099,951 |
| VANGUARD CAPITAL MANAGEMENT LLC | $216.0M | 11,230,748 |
| GEODE CAPITAL MANAGEMENT, LLC | $143.3M | 7,450,769 |
| Nuveen, LLC | $128.3M | 6,673,284 |
| BANK OF AMERICA CORP /DE/ | $104.0M | 5,409,161 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $91.8M | 4,773,303 |
| CENTERSQUARE INVESTMENT MANAGEMENT LLC | $74.6M | 3,877,810 |
More Real Estate Companies
View all Real Estate →Put SBRA on your watchlist
Track score changes the day Sabra Health Care REIT, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is SBRA a good stock to buy?
13F Pro's AI-powered analysis of Sabra Health Care REIT, Inc. (SBRA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Real Estate sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SBRA are available on the SBRA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own SBRA?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SBRA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Sabra Health Care REIT, Inc.'s investment landscape.